3218
J . Org. Chem. 1996, 61, 3218-3220
Sch em e 1
Rea ction of P h osgen im in iu m Sa lts w ith
En ola tes Der ived fr om Lew is Acid
Com p lexes of 2′-Hyd r oxyp r op iop h en on es
a n d Rela ted â-Dik eton es
J oel Morris,* George P. Luke, and Donn G. Wishka
Discovery Chemistry Research, Pharmacia & Upjohn, Inc.,
Kalamazoo, Michigan 49001
Received December 15, 1995
The 2-aminochromone ring system has proven to be a
rich pharmacophore for use in the design of compounds
with a diversity of biological effects that includes unique
antiplatelet derivatives,1 antiproliferative agents,2 and
phosphatidylinositol 3-kinase inhibitors.3 Our interest
in the utilization of this template4,5 as well as the related
2-aminopyrone system6 as part of our medicinal chem-
istry efforts led us to explore a variety of new methods
for their preparation.7 We recently reported a synthesis
of 2-aminochromones (eg 4) that involves the thermal
reaction of boron difluoride complexes of 2′-hydroxy-
acetophenones (or 2′-hydroxypropiophenones) with phos-
gene iminium chloride.4 Hydrolysis of the readily iso-
lated complex 3 with aqueous acetonitrile (or anhydrous
methanol) affords the desired 2-aminochromone 4. This
reaction is successfully performed either by preforming
the boron difluoride complex 2 or through the generation
of this complex in situ by the addition of boron trifluoride
etherate to an ethylene dichloride solution of the starting
2′-hydroxyacetophenone prior to the introduction of the
iminium chloride. As shown in Scheme 1, yields for the
overall conversion of 1a to 4a in both instances are
comparable (47 vs 56%). In contrast, attempts to utilize
this methodology for the conversion of benzoylacetone (6,
R′ ) H) to the 6-phenyl-2-aminopyrones 7a and 7b were
unsuccessful, providing only small amounts of the desired
products (Table 2).8
this sequence. Having previously explored the unravel-
ing of complex 3 to aminochromone 4,9 we chose to focus
on the events surrounding the formation and reaction of
the boron difluoride complex 2. Presumably, heating the
mixture of 2 with phosgene iminium chloride at 80 °C
allows for the generation of significant equilibrium
concentrations of the corresponding enol form of 2 that
is continuously siphoned off as the reaction proceeds. In
this note, we report that the prior enolization of related
Lewis acid complexes of 2 with Hunig’s base provides a
significant improvement to this synthesis that allows for
a smooth reaction with phosgene iminium chloride under
mild conditions (0 °C to rt), producing excellent overall
yields of the 2-aminochromone 4.10,11
We first examined the direct enolization and reaction
of the stable boron difluoride complex 2b. Treatment of
a methylene chloride solution of 2b with 1.2 equiv of
Hunig’s base at 0 °C followed by the addition of phosgene
iminium chloride (0 °C to rt) produced, after a methanol
quench, a 70% yield of 4b (41% overall yield from 1b)
(Table 1). For comparison purposes, this reaction was
also carried out by the in situ generation of 2b and its
subsequent enolization with 2.1 equiv of base, affording
a 33% yield of 4b. In an effort to improve the overall
efficiency of the process, we examined the use of two
alternate Lewis acids. Treatment of 1b with boron
trichloride, followed by enolization of the resultant boron
dichloride complex 5 with 2.1 equiv of Hunig’s base (0
°C), and reaction with phosgene iminium chloride af-
forded an excellent 80% overall isolated yield of 2-
Our desire to improve the overall efficiency of this
process and expand its applicability to related ring
systems (eg 7) prompted us to examine modifications to
(1) Morris, J .; Wishka, D. G.; Lin, A. H.; Humphrey, W. R.; Wiltse,
A. L.; Gammill, R. B.; J udge, T. M.; Bisaha, S. N.; Olds, N. L.; J acob,
C. S.; Bergh, C. L.; Cudahy, M. M.; Williams, D. J .; Nishizawa, E. E.;
Thomas, E. W.; Gorman, R. R.; Benjamin, C. W.; Shebuski, R. J . J .
Med. Chem. 1993, 36, 2026. Mazzei, M.; Balbi, A.; Roma, G.; Di Braccio,
M.; Leoncini, G.; Buzzi, E.; Maresca, M. Eur. J . Med. Chem. 1988, 23,
237. Mazzei, M.; Sottofattori, E; Di Braccio, M.; Balbi, A.; Leoncine,
G.; Buzzi, E.; Maresca, M. Eur. J . Med. Chem. 1990, 25, 617. Leoncini,
G.; Maresca, M.; Colao, C.; Buzzi, E.; Mazzei, M. Cell Biochem. Funct.
1991, 9, 79. Leoncini, G.; Maresca, M.; Colao, C.; Buzzi, E.; Mazzei,
M.; Balbi, A. Pharm. Res. 1991, 23, 139.
(2) Erickson, L. A.; Bonin, P. D.; Wishka, D. G.; Morris, J .; Dalga,
R. J .; Williams, D. J .; Wilson, G. J .; Hoover, J . L.; Simmons, C. A.;
Humphrey, S. J .; Shebuski, R. J . J . Pharm. Exp. Ther. 1994, 271, 415.
(3) Vlahos, C. J .; Matter, W. F.; Hui, K. Y.; Brown, R. F. J . Biol.
Chem. 1994, 269, 5241.
(4) Morris, J .; Wishka, D. G.; Fang, Y. J . Org. Chem. 1992, 57, 6502.
(5) Morris, J .; Wishka, D. G.; Humphrey, W. R.; Lin, A. H.; Wiltse,
A. L.; Benjamin, C. W.; Gorman, R. R.; Shebuski, R. J . Bioorg. Med.
Chem. Lett. 1994, 4, 2621. Morris, J .; Wishka, D. G.; Fang, Y. Synth.
Commun. 1994, 24, 849. Morris, J .; Wishka, D. G.; J ensen, R. M. J .
Org. Chem. 1993, 58, 7277.
(8) The preformed BF2 complex of 6 was reacted with either
phosgene iminium chloride or 4-(dichloromethylene)morpholinium
chloride under the conditions outlined in Table 2. In both examples,
the bulk of the unreacted BF2 compex of 6 was recovered along with
small amounts of 7a or 7b. Moreover, in the reaction producing 7b,
the 4-morpholine iminium salt appeared to decompose at the high
temperature required for reaction.
(9) Morris, J .; Fang, Y.; Wishka, D. G.; Han, F. Tetrahedron Lett.
1993, 34, 3817.
(10) For the reaction of enol borinates with Eschenmoser’s salt,
see: Hooz, J .; Bridson, J . N. J . Am. Chem. Soc. 1973, 95, 602.
(11) For the enolization and subsequent aldol reaction of related
titanium and boron complexes of â-hydroxy ketones, see: Luke, G. P.;
Morris, J . J . Org Chem. 1995, 60, 3013.
(6) Morris, J .; Wishka, D. G. Synthesis 1994, 43.
(7) Ermili, A.; Mazzei, M.; Roma, G.; Cacciatore, C. Farmaco Ed.
Sci. 1977, 32, 375. Ermili, A.; Balbi, A.; Di Braccio, M.; Roma, G.
Farmaco Ed. Sci. 1977, 32, 713. Ermili, A.; Roma, G.; Mazzei, M.; Balbi,
A.; Di Braccio, M.; Schianterelli, P.; Cadel, S. Farmaco Ed. Sci. 1974,
29, 225. Gammill, R. B.; Nash, S. A.; Mizsak, S. A. Tetrahedron Lett.
1983, 24, 3435. Bantick, J . R.; Suschitzky, J . L. J . Heterocycl. Chem.
1981, 18, 679.
S0022-3263(95)02213-4 CCC: $12.00 © 1996 American Chemical Society